Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

Maria Thompson

Maria Thompson, PhD has a background in molecular genetics and over 16 years of experience in pharmaceutical and diagnostics research and development. She has held a variety of roles including Head of Genome Wide Screening for Type 2 diabetes, Six Sigma Black Belt, and VP of Scientific Affairs. Dr. Thompson is a Principal Consultant at APEX Think, a private consulting company providing scientific and technical advisory services to clients across the life science industry. Dr. Thompson holds a BSc in Genetics and a PhD in Molecular and Cellular Biochemistry from the Royal London School of Medicine, UK.
Showing 51-60 of 78 post
Apr 4, 2013

Outsourcing is frequently associated with overseas work, however it encompasses all work that you are sending outside the company,including work to...

Apr 2, 2013

The black mamba’s venom is so potent that one bite spells almost certain death, in the absence of antivenom. At least the snake provides the...

Mar 26, 2013

There’s life down there, deep beneath the ocean floor. Recently reported from scientists at Woods Hole Oceanographic Institute where they collected...

Mar 19, 2013

Successful pharmaceutical outsourcing requires realistic and well-defined expectations, a strong vendor-client relationship, and continued client...

Mar 14, 2013

The internet has connected us in a way never before seen in history: we can now rely on other’s people experiences to guide our own. Whether it is...

Mar 12, 2013

From pharmaceuticals to financial services, the motives that drive outsourcing are fundamental. Top among them are perceived cost savings, improved...

Mar 7, 2013

Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is how the...

Mar 5, 2013

Last week we blogged about the growing trend in pharmaceutical outsourcing. When people hear the word “outsourcing”, many assume that means that...

Feb 28, 2013

The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...

Feb 27, 2013

By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly 15...